BGB-16673-108
Not yet recruiting
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Tacabrutideg (BGB-16673) in Participants With Moderate and Severe Hepatic Impairment
BeOne Study ID
ClinicalTrials.gov ID
Study Overview
Sex:
All
Age: 18 Years / 75 Years
Accepts Healthy Volunteers? yes
No Study Documents
Locations
Study Overview
Sex:
All
Age: 18 Years / 75 Years
Accepts Healthy Volunteers? yes
No Study Documents